Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Akcea Therapeutics Inc. (AKCA)

18.18   -0.27 (-1.46%) 02-21 11:42
Open: 18.45 Pre. Close: 18.45
High: 18.53 Low: 17.94
Volume: 49,761 Market Cap: 1832M
Akcea Therapeutics Inc is a late stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 18.604 - 18.679 18.679 - 18.751
Low: 17.577 - 17.659 17.659 - 17.736
Close: 18.317 - 18.447 18.447 - 18.572

Technical analysis

as of: 2020-02-21 11:24:20 AM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 22.04     One year: 23.48
Support: Support1: 16.89    Support2: 14.05
Resistance: Resistance1: 18.87    Resistance2: 20.10
Pivot: 17.74
Moving Average: MA(5): 18.11     MA(20): 17.94
MA(100): 18.33     MA(250): 21.83
MACD: MACD(12,26):     Signal(9): -0.09
Stochastic oscillator: %K(14,3): 66.10     %D(3): 52.64
RSI: RSI(14): 52.39
52-week: High: 35.82  Low: 13.90  Change(%): -42.8
Average Vol(K): 3-Month: 27437  10-Days: 13447

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
AKCA has closed below upper band by 15.5%. Bollinger Bands are 62.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to AKCA's normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 29 Jan 2020 01:00:49 +0000
Akcea and Ionis Confirm Positive Trial Results for Hypertriglyceridemia Treatment

Thu, 23 Jan 2020 03:14:36 +0000
CNCE Hits Right Notes, BXRX Faces FDA In Feb., All Eyes On AGTC

Wed, 22 Jan 2020 21:53:00 +0000
Akcea and Ionis' Triglyceride-Lowering Drug Works in Mid-Stage Clinical Trial

Wed, 22 Jan 2020 20:31:49 +0000
Health Care Sector Update for 01/22/2020: NTRP,ADAP,AKCA,IONS,HCM

Wed, 22 Jan 2020 18:32:06 +0000
Consumer Sector Update for 01/22/2020: ADAP,AKCA,HCM

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 100.78
Shares Float (M) 9.19
% Held by Insiders 90.11
% Held by Institutions 22.40
Shares Short (K) 4520
Shares Short P. Month (K)

Stock Financials

EPS -1.310
Book Value (p.s.) 3.470
PEG Ratio 0.19
Profit Margin -50.71
Operating Margin -51.97
Return on Assets (ttm) -18.9
Return on Equity (ttm) -37.0
Qtrly Rev. Growth 7.2
Gross Profit (p.s.) -0.734
Sales Per Share
EBITDA (p.s.) -1.069
Qtrly Earnings Growth
Operating Cash Flow (M) -53.63
Levered Free Cash Flow (M) -89.31

Stock Valuations

P/E -13.94
P/E Growth Ratio -0.01
P/BV 5.26
P/S 7.54
P/CF -34.31

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.